Low risk of clostridium difficile infections in hospitalized patients with inflammatory bowel disease in a german tertiary referral center

Digestion

Volumn 84, Issue 3, 2011, Pages 187-192

  Ott, Claudia ^a   Girlich, Christiane ^a   Klebl, Frank ^a   Plentz, Annelie ^a   Iesalnieks, Igors ^b   Schölmerich, Jürgen ^a   Obermeier, Florian ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b Department of Surgery ^*  (Germany)

Author keywords

Clostridium difficile infection; Crohn's disease; Immunosuppressive therapy; Inflammatory bowel disease; Ulcerative colitis

Indexed keywords

ANTIBIOTIC AGENT; IMMUNOSUPPRESSIVE AGENT;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; CROHN DISEASE; DIARRHEA; DISEASE SEVERITY; ENTERITIS; FEMALE; GERMANY; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT REFERRAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TERTIARY HEALTH CARE; TREATMENT OUTCOME; ULCERATIVE COLITIS;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; AZATHIOPRINE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; GERMANY; HOSPITALIZATION; HOSPITALS, UNIVERSITY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; METRONIDAZOLE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 79957828640     PISSN: 00122823     EISSN: 14219867     Source Type: Journal    
DOI: 10.1159/000324617     Document Type: Article

References (20)

1. Issa M, Ananthakrishnan AN, Binion DG: Clostridium difficile and inflammatory bowel disease. Inflamm Bowel Dis 2008; 14: 1432-1442.
2. Gould CV, McDonald LC: Bench-to-bedside review: Clostridium difficile colitis. Crit Care 2008; 12: 203.
3. Morgan OW, Rodrigues B, Elston T, Verlander NQ, Brown DF, Brazier J, Reacher M: Clinical severity of Clostridium difficile PCR ribotype 027: a case-case study. PLoS ONE 2008; 3:e1812.
4. Borgmann S, Kist M, Jakobiak T, Reil M, Scholz E, von Eichel-Streiber C, Gruber H, Brazier JS, Schulte B: Increased number of Clostridium difficile infections and prevalence of Clostridium difficile PCR ribotype in southern Germany. Euro Surveill 2008; 13:pii 19057.
5. Kuijper EJ, Barbut F, Brazier JS, et al: Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008. Euro Surveill 2008; 13:pii 18942.
6. Rodemann JF, Dubberke ER, Reske KA, Seo da H, Stone CD: Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin Gastroenterol Hepatol 2007; 5: 339-344. (Pubitemid 46401530)
7. Ananthakrishnan AN, McGinley EL, Binion DG: Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease. Gut 2008; 57: 205-210. (Pubitemid 351158048)
8. Nguyen GC, Kaplan GG, Harris ML, Brant SR: A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients. Am J Gastroenterol 2008; 103: 1443-1450. (Pubitemid 351813903)
9. Ricciardi R, Ogilvie JW Jr, Roberts PL, Marcello PW, Concannon TW, Baxter NN: Epidemiology of Clostridium difficile colitis in hospitalized patients with inflammatory bowel diseases. Dis Colon Rectum 2009; 52: 40-45.
10. Issa M, Vijayapal A, Graham MB, et al: Impact of Clostridium difficile on inflammatory bowel disease. Clin Gastroenterol Hepatol 2007; 5: 345-351. (Pubitemid 46401531)
11. Mantzaris GJ CA, Karakoidas C, Papamichael K, Agalos G, Smyrnidis A, Kanellopoulos N, Raptis N, Panaiara O: Ulcerative colitis and Clostridium difficile infection: a changing field. Gut 2008; 57: 205-210.
12. Bossuyt P, Verhaegen J, Van Assche G, Rutgeerts P, Vermeire S: Increasing incidence of Clostridium difficile-associated diarrhea in inflammatory bowel disease. J Crohns Colitis 2009; 3: 4-7.
13. Pascarella F, Martinelli M, Miele E, Del Pezzo M, Roscetto E, Staiano A: Impact of Clostridium difficile infection on pediatric inflammatory bowel disease. J Pediatr 2009; 154: 854-858.
14. Archibald LK, Banerjee SN, Jarvis WR: Secular trends in hospital-acquired Clostridium difficile disease in the United States, 1987-2001. J Infect Dis 2004; 189: 1585-1589. (Pubitemid 38648285)
15. Mylonaki M, Langmead L, Pantes A, Johnson F, Rampton DS: Enteric infection in relapse of inflammatory bowel disease: importance of microbiological examination of stool. Eur J Gastroenterol Hepatol 2004; 16: 775-778. (Pubitemid 39062569)
16. Navaneethan U, Venkatesh PG, Shen B: Clostridium difficile infection and inflammatory bowel disease: understanding the evolving relationship. World J Gastroenterol 2010; 16: 4892-4904.
17. Nemat H, Khan R, Ashraf MS, et al: Diagnostic value of repeated enzyme immunoassays in Clostridium difficile infection. Am J Gastroenterol 2009; 104: 2035-2041.
18. Litvin M, Reske KA, Mayfield J, McMullen KM, Georgantopoulos P, Copper S, Hoppe-Bauer JE, Fraser VJ, Warren DK, Dubberke ER: Identification of a pseudo-outbreak of Clostridium difficile infection (CDI) and the effect of repeated testing, sensitivity, and specificity on perceived prevalence of CDI. Infect Control Hosp Epidemiol 2009; 30: 1166-1171.
19. Freeman HJ: Recent developments on the role of Clostridium difficile in inflammatory bowel disease. World J Gastroenterol 2008; 14: 2794-2796.
20. Wang Y, Shen B: Clostridium difficile-associated diarrhea in Crohn's disease patients with ostomy. Inflamm Bowel Dis 2010; 16: 1-2.